The Pfizer-BioNTech alliance has started recruiting for a clinical trial which aims to test, on adults aged 55 and under, the safety and immune response of their vaccine against Covid-19 which specifically targets the Omicron variant. the two companies announced on Tuesday.
” READ ALSO –
Pfizer-BioNTech begins clinical trial of a vaccine against Omicron